DE1817466C3 - Verfahren zur Herstellung von intravenös injizierbaren und pyrogen freien Salzen des Lysozyms - Google Patents

Verfahren zur Herstellung von intravenös injizierbaren und pyrogen freien Salzen des Lysozyms

Info

Publication number
DE1817466C3
DE1817466C3 DE1817466A DE1817466A DE1817466C3 DE 1817466 C3 DE1817466 C3 DE 1817466C3 DE 1817466 A DE1817466 A DE 1817466A DE 1817466 A DE1817466 A DE 1817466A DE 1817466 C3 DE1817466 C3 DE 1817466C3
Authority
DE
Germany
Prior art keywords
lysozyme
solution
placenta
phosphate buffer
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1817466A
Other languages
German (de)
English (en)
Other versions
DE1817466A1 (de
DE1817466B2 (de
Inventor
Kenichi Kadoma Izaka
Hiroshi Yamatotakada Shirakawa
Tadakazu Hirakata Suyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Green Cross Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp filed Critical Green Cross Corp
Publication of DE1817466A1 publication Critical patent/DE1817466A1/de
Publication of DE1817466B2 publication Critical patent/DE1817466B2/de
Application granted granted Critical
Publication of DE1817466C3 publication Critical patent/DE1817466C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y10S435/815—Enzyme separation or purification by sorption

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DE1817466A 1968-07-16 1968-12-30 Verfahren zur Herstellung von intravenös injizierbaren und pyrogen freien Salzen des Lysozyms Expired DE1817466C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5012168 1968-07-16

Publications (3)

Publication Number Publication Date
DE1817466A1 DE1817466A1 (de) 1970-07-09
DE1817466B2 DE1817466B2 (de) 1973-02-22
DE1817466C3 true DE1817466C3 (de) 1973-10-04

Family

ID=12850272

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1817466A Expired DE1817466C3 (de) 1968-07-16 1968-12-30 Verfahren zur Herstellung von intravenös injizierbaren und pyrogen freien Salzen des Lysozyms

Country Status (3)

Country Link
US (1) US3627642A (enExample)
DE (1) DE1817466C3 (enExample)
FR (1) FR1604237A (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019991B2 (ja) * 1982-06-02 1985-05-18 キユーピー株式会社 卵白リゾチ−ムの結晶化方法
HU191563B (en) * 1984-10-26 1987-03-30 Reanal Finomvegyszergyar Process for preparing lysozyme enzyme
DE3818094C1 (enExample) * 1988-05-27 1989-07-20 Medichemie Ag, Ettingen, Ch
CN118510910A (zh) * 2022-01-10 2024-08-16 塞提斯生物技术有限公司 用于处理含核酸样品的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2806815A (en) * 1955-04-12 1957-09-17 Ortho Pharma Corp Stabilized hyaluronidase

Also Published As

Publication number Publication date
US3627642A (en) 1971-12-14
FR1604237A (enExample) 1971-10-04
DE1817466A1 (de) 1970-07-09
DE1817466B2 (de) 1973-02-22

Similar Documents

Publication Publication Date Title
EP0103196B2 (de) Pasteurisiertes Human-Fibrinogen (HF), Verfahren zu dessen Herstellung und dessen Verwendung
DE1617447B1 (de) Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates
DE3240174A1 (de) Neue plasminogen-aktivatorderivate
EP0013901A1 (de) Verfahren zur Herstellung einer für die intravenöse Applikation geeigneten Immunglobulinlösung, die IgM in ankonzentrierter Form enthält
DE2440529C3 (de) Hyaluronidase-Präparat aus menschlicher Plazenta
DE4021979A1 (de) Verfahren zur reinigung von annexinen
DE3687097T2 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
AT391808B (de) Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
EP0271885B1 (de) Arzneimittel enthaltend das Gewebeprotein PP4, Verfahren zur Herstellung von PP4 und zu seiner Pasteurisierung sowie die Verwendung von PP4
EP0129534B1 (de) Verfahren zur Herstellung eines Antithrombin III-Heparin- bzw. Antithrombin III-Heparinoid-Konzentrates
DE68908426T2 (de) Adjuvanz für Krebsimmuntherapie.
CH628246A5 (de) Verfahren zur herstellung eines schuetzenden pertussis-antigens.
DE1817466B2 (de) Verfahren zur herstellung von intravenoes injizierbaren und pyrogenfreien salzen des lysozyms
DE1076888B (de) Verfahren zur Gewinnung atmungsfoerdernder Wirkstoffe fuer therapeutische Zwecke
DE2307051B2 (de) Verfahren zum Reinigen von langsamen a - und ß -Glykoproteinen aus Mikrobenkörpern und diese enthaltende pharmazeutische Zusammensetzungen
DE69428020T2 (de) Topische antibakterielle Zusammensetzung
DE2910745A1 (de) Glykoproteid aus menschlichem urin, verfahren zu seiner herstellung und seine verwendung bei der bekaempfung von leukozytopenie
DE1792196A1 (de) Verfahren zur Stabilisierung eines Proteins
CH640244A5 (en) Biologically active substance
DE3787451T2 (de) Antibakterielles Mittel für Anwendung bei Säugetieren mit Cephalosporinverbindungen als effektiven Bestandteil.
CH628682A5 (de) Diagnostisches mittel zum testen der suszeptibilitaet von bakterien gegenueber die bildung von folsaeure hemmenden mitteln.
DE2828944C2 (de) Verfahren zur Herstellung von Lysozym
DE3619565A1 (de) Verfahren zur herstellung einer pasteurisierten immunglobulinpraeparation
CH621557A5 (enExample)
AT392003B (de) Verfahren zur herstellung eines insbesondere zur wundheilung oder zur behandlung in der geriatrie verwendbaren wirkstoffes aus saeugetierblut durch papainhydrolyse und ein einen solchen wirkstoff enthaltendes praeparat

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
E77 Valid patent as to the heymanns-index 1977
EHJ Ceased/non-payment of the annual fee